Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-17-051984

Director disposed of 2,614,157 shares (other)

  • Director acquired 366,499 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −1,368,013 2,736,032 I: show line 1 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −8,110 16,224 I: show line 2 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −814,599 1,629,204 I: show line 3 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −23,899 47,801 I: show line 4 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −61,993 123,994 I: show line 5 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −26,491 52,987 I: show line 6 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other acquisition +292,529 292,529 I: show line 7 in the form
Bolzon Bradley J PhD Director 2017-09-05 Other disposition −292,529 0 I: show line 8 in the form
Loading xslF345X03/doc4.xml…